Peloton Wealth Strategists’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-9,350
Closed -$1.66M 76
2020
Q1
$1.66M Sell
9,350
-1,300
-12% -$245K 1.35% 33
2019
Q4
$2.04M Sell
10,650
-1,000
-9% -$180K 1.24% 35
2019
Q3
$1.96M Sell
11,650
-4,900
-30% -$798K 1.25% 35
2019
Q2
$2.77M Sell
16,550
-400
-2% -$55.4K 1.86% 22
2019
Q1
$2.48M Buy
16,950
+100
+0.6% +$14.5K 1.72% 27
2018
Q4
$2.25M Sell
16,850
-3,657
-18% -$599K 1.83% 24
2018
Q3
$3.91M Buy
+20,507
New +$3.77M 2.69% 6
2018
Q1
Sell
-14,185
Closed -$2.32M 69
2017
Q4
$2.32M Buy
14,185
+3,700
+35% +$664K 1.72% 29
2017
Q3
$2.15M Buy
10,485
+2,835
+37% +$659K 1.66% 27
2017
Q2
$1.86M Buy
+7,650
New +$1.8M 1.44% 31
2015
Q2
Sell
-4,897
Closed -$1.46M 76
2015
Q1
$1.46M Buy
+4,897
New +$1.4M 1.13% 44

Other funds holding AGN

Peloton Wealth Strategists's AGN Position: Q2 2020 in Review

Peloton Wealth Strategists sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 9,350 shares — an estimated $1.66M sold.

Peloton Wealth Strategists first reported a position in AGN in Q1 2015 and held it in 11 quarters. The position peaked at $3.91M in Q3 2018. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Peloton Wealth Strategists reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Peloton Wealth Strategists sold 9,350 Allergan plc shares in Q2 2020, an estimated $1.66M.
  • Peloton Wealth Strategists first reported a position in Allergan plc in Q1 2015 and held it in 11 quarters.
  • Peloton Wealth Strategists's Allergan plc position peaked at $3.91M in Q3 2018.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Peloton Wealth Strategists's 13F filing for Q2 2020, filed 13 Aug 2020.